| Literature DB >> 28279666 |
Daniele Masarone1, Fabio Valente2, Marta Rubino2, Rossella Vastarella2, Rita Gravino2, Alessandra Rea2, Maria Giovanna Russo2, Giuseppe Pacileo2, Giuseppe Limongelli2.
Abstract
Pediatric heart failure represents an important cause of morbidity and mortality in childhood. Currently, there are well-established guidelines for the management of heart failure in the adult population, but an equivalent consensus in children is lacking. In the clinical setting, ensuring an accurate diagnosis and defining etiology is essential to optimal treatment. Diuretics and angiotensin-converting enzyme inhibition are the first-line therapies, whereas beta-blockers and devices for electric therapy are less used in children than in adults. In the end-stage disease, heart transplantation is the best choice of treatment, while a left ventricular assist device can be used as a bridge to transplantation (due to the difficulties in finding organ donors), recovery (in the case of myocarditis), or destination therapy (for patients with systemic disease).Entities:
Keywords: cardiomyopathies; congenital heart diseases; pediatric cardiac transplantation; pediatric heart failure
Mesh:
Substances:
Year: 2017 PMID: 28279666 DOI: 10.1016/j.pedneo.2017.01.001
Source DB: PubMed Journal: Pediatr Neonatol ISSN: 1875-9572 Impact factor: 2.083